Pharmaceutical Product Development Inc PPDI Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Myotonic Dystrophy - Pipeline Review, H1 2015

Myotonic Dystrophy - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 61 pages

Myotonic Dystrophy - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Myotonic Dystrophy - Pipeline Review, H1 2015', provides an overview of the Myotonic Dystrophy's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, ...

Industries: Drug Discovery and Development | Countries: World, United States

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • January 2015
  • 42 pages

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015', provides an overview of the Proliferative Vitreoretinopathy (PVR)'s therapeutic pipeline. This report provides comprehensive information ...

Industries: Drug Discovery and Development | Countries: World, United States

Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015

Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • by Global Data
  • January 2015
  • 64 pages

Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015" provides data on the Alcoholic Hepatitis clinical trial scenario. This report provides elemental information and data relating to the ...

Industries: Drug Discovery and Development | Countries: World, United States

Cholelithiasis Global Clinical Trials Review, H1, 2015

Cholelithiasis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • by Global Data
  • January 2015
  • 61 pages

Cholelithiasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, H1, 2015" provides data on the Cholelithiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Industries: Drug Discovery and Development | Countries: World, United States

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • by Global Data
  • January 2015
  • 83 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2015" provides data on the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) ...

Industries: Drug Discovery and Development | Countries: United States, World

Spaulding Clinical Research, LLC - Medical Equipment - Deals and Alliances Profile

Spaulding Clinical Research, LLC - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2015
  • 16 pages

Summary Spaulding Clinical Research, LLC (Spaulding Clinical Research) is a clinical research and medical device company. The company specializes in clinical pharmacology research. Its products include spaulding electrocardiograph and Spaulding webECG. Spaulding Clinical Research provides data management ...

Industries: Drug Discovery and Development | Countries: United States

Nanoen Tek, Inc. (Symbol:039860) SWOT Analysis, Strategy, Revenues and Profits

Nanoen Tek, Inc. (Symbol:039860) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Nanoen Tek, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug Discovery and Development | Countries: South Korea, United States

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. JCL Bioassay Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug Discovery and Development | Countries: United States, Japan

MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review

MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary MEI Pharma, Inc. (MEI) is an oncology company. The company provides clinical development of therapeutics for the treatment of cancer. It develops cancer therapeutic with the help of naturally occurring compound Isoflavones. The company has developed two vaccine for the treatment of cancer ME-143 ...

Industries: Drug Discovery and Development | Countries: United States

DATATRAK International, Inc. (DTRK) - Financial and Strategic SWOT Analysis Review

DATATRAK International, Inc. (DTRK) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary DATATRAK International, Inc. (DATATRAK) is a healthcare information technology company. The company provides e-clinical solutions and related services for the clinical trials industry. Its products include uCTMS, uDesign, uEDC, uIRT, uSafety, uTrain and uCDR. The company offers products to design, ...

Industries: Drug Discovery and Development | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.